id	occurrenceID	measurementType	measurementValue
ptr.8084_039	ptr.8084_039	Extraction method and solvent	Methanol extract
ptr.8084_039	ptr.8084_039	Isolated compound (Class of compound)	Oleanolic acid  (triterpene acide)
ptr.8084_039	ptr.8084_039	Assay employed	Plaque reduction assay
ptr.8084_039	ptr.8084_039	Cell line used	Vero cell lines
ptr.8084_039	ptr.8084_039	Virus	Herpes Simplex Virus type 1 (HSV 1), Herpes Simplex Virus type 2 (HSV 2)
ptr.8084_039	ptr.8084_039	IC50/ED50/EC50/CC50	EC50 (6.8 µg/ml), EC50 (7.8 µg/ml)
ptr.8084_040	ptr.8084_040	Extraction method and solvent	Hydroalcoholic extracts
ptr.8084_040	ptr.8084_040	Isolated compound (Class of compound)	none
ptr.8084_040	ptr.8084_040	Assay employed	Cytopathogenic effect
ptr.8084_040	ptr.8084_040	Cell line used	Human cervix carcinoma (HeLa) cell lines
ptr.8084_040	ptr.8084_040	Virus	Coxsackievirus B3
ptr.8084_040	ptr.8084_040	IC50/ED50/EC50/CC50	IC50 (1.34 µg/ml)
ptr.8084_041	ptr.8084_041	Extraction method and solvent	Petroleum ether
ptr.8084_041	ptr.8084_041	Isolated compound (Class of compound)	none
ptr.8084_041	ptr.8084_041	Assay employed	MTT
ptr.8084_041	ptr.8084_041	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_041	ptr.8084_041	Virus	Human Immunodeficiency Virus type 1 (HIV 1), Human Immunodeficiency Virus type 2 (HIV 2)
ptr.8084_041	ptr.8084_041	IC50/ED50/EC50/CC50	EC50 (>125µg/ml)
ptr.8084_042	ptr.8084_042	Extraction method and solvent	Hydro-distilled esential oil
ptr.8084_042	ptr.8084_042	Isolated compound (Class of compound)	none
ptr.8084_042	ptr.8084_042	Assay employed	Cytopathogenic effect
ptr.8084_042	ptr.8084_042	Cell line used	Vero cell lines
ptr.8084_042	ptr.8084_042	Virus	HSV 1
ptr.8084_042	ptr.8084_042	IC50/ED50/EC50/CC50	EC50 (1060µg/ml) at the concentration of 200 µg/ml oil
ptr.8084_043	ptr.8084_043	Extraction method and solvent	Methyl alcohol extract
ptr.8084_043	ptr.8084_043	Isolated compound (Class of compound)	Plaque reduction assay
ptr.8084_043	ptr.8084_043	Assay employed	Allantoic,
ptr.8084_043	ptr.8084_043	Cell line used	cavity of embryonated chicken eggs; Rabbit skin cells; Fetal rhesus monkey kidney cell lines
ptr.8084_043	ptr.8084_043	Virus	Influenza B virus; HSV; Hepatitis A virus
ptr.8084_043	ptr.8084_043	IC50/ED50/EC50/CC50	≥0.15 mg/ml; ≥0.015 mg/ml; 50 mg/ml
ptr.8084_043	ptr.8084_043	Mechanism of action	Significantly reduced the infectivity titer of both viruses; Significantly reduced titer by 2.10 ± 0.41 logs
ptr.8084_044	ptr.8084_044	Extraction method and solvent	Methanol
ptr.8084_044	ptr.8084_044	Isolated compound (Class of compound)	none
ptr.8084_044	ptr.8084_044	Assay employed	Cytopathogenic effect
ptr.8084_044	ptr.8084_044	Cell line used	Vero cell lines
ptr.8084_044	ptr.8084_044	Virus	HSV; Sindbis virus
ptr.8084_044	ptr.8084_044	IC50/ED50/EC50/CC50	MIC (100 µg/µl)
ptr.8084_045	ptr.8084_045	Extraction method and solvent	Hydroalcolic extract
ptr.8084_045	ptr.8084_045	Isolated compound (Class of compound)	none
ptr.8084_045	ptr.8084_045	Assay employed	MTT
ptr.8084_045	ptr.8084_045	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_045	ptr.8084_045	Virus	HIV 1; HIV 2
ptr.8084_045	ptr.8084_045	IC50/ED50/EC50/CC50	EC50 (>103 µg/ml)
ptr.8084_046	ptr.8084_046	Extraction method and solvent	Ethanol extract
ptr.8084_046	ptr.8084_046	Isolated compound (Class of compound)	none
ptr.8084_046	ptr.8084_046	Assay employed	HIV-1 integrase colorimetric immunoassay
ptr.8084_046	ptr.8084_046	Cell line used	none
ptr.8084_046	ptr.8084_046	Virus	HIV 1
ptr.8084_046	ptr.8084_046	IC50/ED50/EC50/CC50	IC50 (<100 µg/ml)
ptr.8084_046	ptr.8084_046	Mechanism of action	Inhibition of HIV-1 integrase
ptr.8084_047	ptr.8084_047	Extraction method and solvent	Dichloromethane and methanol
ptr.8084_047	ptr.8084_047	Isolated compound (Class of compound)	none
ptr.8084_047	ptr.8084_047	Assay employed	Dye uptake assay
ptr.8084_047	ptr.8084_047	Cell line used	Vero cell lines
ptr.8084_047	ptr.8084_047	Virus	Human influenza virus A/WSN/33 (H1N1)
ptr.8084_047	ptr.8084_047	IC50/ED50/EC50/CC50	IC50 (50 µg/ml)
ptr.8084_048	ptr.8084_048	Extraction method and solvent	Hydroalcoholic extracts
ptr.8084_048	ptr.8084_048	Isolated compound (Class of compound)	none
ptr.8084_048	ptr.8084_048	Assay employed	MTT
ptr.8084_048	ptr.8084_048	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_048	ptr.8084_048	Virus	HIV 1; HIV 2
ptr.8084_048	ptr.8084_048	IC50/ED50/EC50/CC50	EC50 (>2.3 µg/ml)
ptr.8084_049	ptr.8084_049	Extraction method and solvent	Hydroalcoholic extracts
ptr.8084_049	ptr.8084_049	Isolated compound (Class of compound)	Ombuin  (flavonoid)
ptr.8084_049	ptr.8084_049	Assay employed	Plaque reduction assay
ptr.8084_049	ptr.8084_049	Cell line used	Madin-Darby canine kidney cell lines
ptr.8084_049	ptr.8084_049	Virus	Avian influenza virus A (H5N1)
ptr.8084_049	ptr.8084_049	IC50/ED50/EC50/CC50	80 µg/ml of the extract inhibits 63%; 20 µg/ml
ptr.8084_050	ptr.8084_050	Extraction method and solvent	Hydroalcoholic extracts
ptr.8084_050	ptr.8084_050	Isolated compound (Class of compound)	none
ptr.8084_050	ptr.8084_050	Assay employed	MTT
ptr.8084_050	ptr.8084_050	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_050	ptr.8084_050	Virus	HIV 1; HIV 2
ptr.8084_050	ptr.8084_050	IC50/ED50/EC50/CC50	EC50 (>125 µg/ml)
ptr.8084_051	ptr.8084_051	Extraction method and solvent	Methanolic extract
ptr.8084_051	ptr.8084_051	Isolated compound (Class of compound)	none
ptr.8084_051	ptr.8084_051	Assay employed	Plaque assay
ptr.8084_051	ptr.8084_051	Cell line used	Vero cell lines
ptr.8084_051	ptr.8084_051	Virus	HSV-1; HSV-2
ptr.8084_051	ptr.8084_051	IC50/ED50/EC50/CC50	25 µg/ml
ptr.8084_052	ptr.8084_052	Extraction method and solvent	Methanolic extract
ptr.8084_052	ptr.8084_052	Isolated compound (Class of compound)	none
ptr.8084_052	ptr.8084_052	Assay employed	Reverse transcriptase assay; enzyme-linked immunosorbent assay (ELISA)
ptr.8084_052	ptr.8084_052	Cell line used	none
ptr.8084_052	ptr.8084_052	Virus	HIV 1; Hepatitis B
ptr.8084_052	ptr.8084_052	IC50/ED50/EC50/CC50	91±0.02 % inhibition; 78.9±0.01 % inhibition
ptr.8084_053	ptr.8084_053	Extraction method and solvent	Aqueous extract
ptr.8084_053	ptr.8084_053	Isolated compound (Class of compound)	none
ptr.8084_053	ptr.8084_053	Assay employed	MTT
ptr.8084_053	ptr.8084_053	Cell line used	Molt-4
ptr.8084_053	ptr.8084_053	Virus	HIV 1; HIV 2
ptr.8084_053	ptr.8084_053	IC50/ED50/EC50/CC50	EC50 (0.7 mg/ml); EC50 (0.11 mg/ml)
ptr.8084_054	ptr.8084_054	Extraction method and solvent	Ethanol extract
ptr.8084_054	ptr.8084_054	Isolated compound (Class of compound)	none
ptr.8084_054	ptr.8084_054	Assay employed	Cytopathogenic effect
ptr.8084_054	ptr.8084_054	Cell line used	Human T-lymphocytic
ptr.8084_054	ptr.8084_054	Virus	HIV 1
ptr.8084_054	ptr.8084_054	IC50/ED50/EC50/CC50	EC50 (114.2 µg/ml)
ptr.8084_055	ptr.8084_055	Extraction method and solvent	Hydroalcoholic extracts
ptr.8084_055	ptr.8084_055	Isolated compound (Class of compound)	none
ptr.8084_055	ptr.8084_055	Assay employed	MTT
ptr.8084_055	ptr.8084_055	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_055	ptr.8084_055	Virus	HIV 1; HIV 2
ptr.8084_055	ptr.8084_055	IC50/ED50/EC50/CC50	EC50 (>118.5 µg/ml)
ptr.8084_056	ptr.8084_056	Extraction method and solvent	Seed oil
ptr.8084_056	ptr.8084_056	Isolated compound (Class of compound)	none
ptr.8084_056	ptr.8084_056	Assay employed	Cytopathogenic effect
ptr.8084_056	ptr.8084_056	Cell line used	Madin-Darby canine kidney cell lines
ptr.8084_056	ptr.8084_056	Virus	Parainfluenza virus type-3
ptr.8084_056	ptr.8084_056	IC50/ED50/EC50/CC50	16-8 μg/mL
ptr.8084_057	ptr.8084_057	Extraction method and solvent	Ethanol extract
ptr.8084_057	ptr.8084_057	Isolated compound (Class of compound)	none
ptr.8084_057	ptr.8084_057	Assay employed	HIV inhibition assay
ptr.8084_057	ptr.8084_057	Cell line used	MT-4
ptr.8084_057	ptr.8084_057	Virus	HIV 1
ptr.8084_057	ptr.8084_057	IC50/ED50/EC50/CC50	EC50 (>128.01 µg/ml)
ptr.8084_058	ptr.8084_058	Extraction method and solvent	none
ptr.8084_058	ptr.8084_058	Isolated compound (Class of compound)	none
ptr.8084_058	ptr.8084_058	Assay employed	Plaque assay
ptr.8084_058	ptr.8084_058	Cell line used	Vero cell line
ptr.8084_058	ptr.8084_058	Virus	HSV-1
ptr.8084_058	ptr.8084_058	IC50/ED50/EC50/CC50	0.1%; EC50 (45.270±4.31  to >100 μg/ml)
ptr.8084_058	ptr.8084_058	Mechanism of action	Direct interaction with virions; on the post-adsorptive phase of
ptr.8084_059	ptr.8084_059	Extraction method and solvent	Hydroalcoholic extract
ptr.8084_059	ptr.8084_059	Isolated compound (Class of compound)	none
ptr.8084_059	ptr.8084_059	Assay employed	MTT
ptr.8084_059	ptr.8084_059	Cell line used	Vero cell line
ptr.8084_059	ptr.8084_059	Virus	HSV-1
ptr.8084_059	ptr.8084_059	IC50/ED50/EC50/CC50	EC50 (45.270±4.31  to >100 μg/ml)
ptr.8084_059	ptr.8084_059	Mechanism of action	on the post-adsorptive phase of
ptr.8084_060	ptr.8084_060	Extraction method and solvent	Methanol fraction
ptr.8084_060	ptr.8084_060	Isolated compound (Class of compound)	none
ptr.8084_060	ptr.8084_060	Assay employed	MTT
ptr.8084_060	ptr.8084_060	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_060	ptr.8084_060	Virus	HIV 1; HIV 2
ptr.8084_060	ptr.8084_060	IC50/ED50/EC50/CC50	EC50 (>0.6 µg/ml)
ptr.8084_061	ptr.8084_061	Extraction method and solvent	Dichloromethanol extract
ptr.8084_061	ptr.8084_061	Isolated compound (Class of compound)	none
ptr.8084_061	ptr.8084_061	Assay employed	MTT
ptr.8084_061	ptr.8084_061	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_061	ptr.8084_061	Virus	HIV 1; HIV 2
ptr.8084_061	ptr.8084_061	IC50/ED50/EC50/CC50	EC50 (>3.8 µg/ml)
ptr.8084_062	ptr.8084_062	Extraction method and solvent	Dichloromethanol extract
ptr.8084_062	ptr.8084_062	Isolated compound (Class of compound)	none
ptr.8084_062	ptr.8084_062	Assay employed	Cytopathogenic effect
ptr.8084_062	ptr.8084_062	Cell line used	Vero cell line
ptr.8084_062	ptr.8084_062	Virus	Canine distemper virus; Canine parainfluenza virus-2
ptr.8084_062	ptr.8084_062	IC50/ED50/EC50/CC50	EC50 (30.9 μg/ml)
ptr.8084_063	ptr.8084_063	Extraction method and solvent	Crude alkaloidal extract
ptr.8084_063	ptr.8084_063	Isolated compound (Class of compound)	none
ptr.8084_063	ptr.8084_063	Assay employed	MTT
ptr.8084_063	ptr.8084_063	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_063	ptr.8084_063	Virus	HIV-1
ptr.8084_063	ptr.8084_063	IC50/ED50/EC50/CC50	EC50 (>53 µM)
ptr.8084_063	ptr.8084_063	Mechanism of action	Induced cytopathogeneticy
ptr.8084_064	ptr.8084_064	Extraction method and solvent	Methanol extract
ptr.8084_064	ptr.8084_064	Isolated compound (Class of compound)	none
ptr.8084_064	ptr.8084_064	Assay employed	Cytopathogenic effect
ptr.8084_064	ptr.8084_064	Cell line used	Human  rhabdomyosarcom cell line
ptr.8084_064	ptr.8084_064	Virus	Echovirus; Coxsackievirus B
ptr.8084_064	ptr.8084_064	IC50/ED50/EC50/CC50	6.5 mg/ml
ptr.8084_065	ptr.8084_065	Extraction method and solvent	Ethanol extract (Dichloromethanol fraction); Esential oil
ptr.8084_065	ptr.8084_065	Isolated compound (Class of compound)	none
ptr.8084_065	ptr.8084_065	Assay employed	Plaque reduction assay
ptr.8084_065	ptr.8084_065	Cell line used	Human hepatoma cell line (Huh7it); RC-37 cells
ptr.8084_065	ptr.8084_065	Virus	HSV 1; HSV 2
ptr.8084_065	ptr.8084_065	IC50/ED50/EC50/CC50	IC50 (0.009%); IC50 (0.008%)
ptr.8084_066	ptr.8084_066	Extraction method and solvent	Methanol extract
ptr.8084_066	ptr.8084_066	Isolated compound (Class of compound)	none
ptr.8084_066	ptr.8084_066	Assay employed	Reverse transcriptase assay
ptr.8084_066	ptr.8084_066	Cell line used	MT4
ptr.8084_066	ptr.8084_066	Virus	HIV 1
ptr.8084_066	ptr.8084_066	IC50/ED50/EC50/CC50	IC50 (5±0.5 μg/ml
ptr.8084_067	ptr.8084_067	Extraction method and solvent	Ethanol extracts of Latex; Hexanic and hexane–ethyl acetate extracts of latex
ptr.8084_067	ptr.8084_067	Isolated compound (Class of compound)	none
ptr.8084_067	ptr.8084_067	Assay employed	Plaque reduction assay
ptr.8084_067	ptr.8084_067	Cell line used	Madin-Darby canine kidney cell lines
ptr.8084_067	ptr.8084_067	Virus	Caprine herpes virus-1; HSV 1; Echovirus type 11; Adenovirus
ptr.8084_067	ptr.8084_067	IC50/ED50/EC50/CC50	Complete inhibition at 100 μg/ml; Inhibited the multiplication at 78 μg/ml
ptr.8084_068	ptr.8084_068	Extraction method and solvent	n-hexane extracts
ptr.8084_068	ptr.8084_068	Isolated compound (Class of compound)	none
ptr.8084_068	ptr.8084_068	Assay employed	Cytopathogenic effect
ptr.8084_068	ptr.8084_068	Cell line used	Vero cell lines
ptr.8084_068	ptr.8084_068	Virus	Vesicular stomatitis virus
ptr.8084_068	ptr.8084_068	IC50/ED50/EC50/CC50	100 μg/ml
ptr.8084_068	ptr.8084_068	Mechanism of action	Reduction of the titer of 102
ptr.8084_069	ptr.8084_069	Extraction method and solvent	Methanol
ptr.8084_069	ptr.8084_069	Isolated compound (Class of compound)	3β,12-dihydroxy-13-methylpodocarpa-6,8,11,13-tetraene  (dinorditerpenes) ; Spruceanol (dinorditerpenes);  7α,20-epoxy-3α-hydroxy-12-methoxy-13-methyl-ent-podocarp8,11,13-triene  (dinorditerpenes); 3α,20-epoxy-3β-hydroxy-12-methoxy13-methyl-ent-podocarp-8,11,13-triene  (dinorditerpenes); 3β,12-Dihydroxy-13-methylpodocarpa-8,11,13-triene  (dinorditerpenes)
ptr.8084_069	ptr.8084_069	Assay employed	Luciferase activity assay
ptr.8084_069	ptr.8084_069	Cell line used	Human hepatoma Huh7 cell lines
ptr.8084_069	ptr.8084_069	Virus	HCV
ptr.8084_069	ptr.8084_069	IC50/ED50/EC50/CC50	EC50 (5.6 μM); EC50 (5.0 μM); EC50 (7.5 μM); EC50 (6.6 μM); EC50 (12 μM)
ptr.8084_070	ptr.8084_070	Extraction method and solvent	Hydrodistillation of esential oil
ptr.8084_070	ptr.8084_070	Isolated compound (Class of compound)	Many components
ptr.8084_070	ptr.8084_070	Assay employed	Plaque reduction assay
ptr.8084_070	ptr.8084_070	Cell line used	Vero cell lines
ptr.8084_070	ptr.8084_070	Virus	HCV-1; Parainfluenza (type-3)
ptr.8084_070	ptr.8084_070	IC50/ED50/EC50/CC50	EC50 (0.2 to 0.4 μM); EC50 (0.4 to 0.8 μM)
ptr.8084_070	ptr.8084_070	Mechanism of action	Several targets
ptr.8084_071	ptr.8084_071	Extraction method and solvent	Hydroalcoholic extract
ptr.8084_071	ptr.8084_071	Isolated compound (Class of compound)	none
ptr.8084_071	ptr.8084_071	Assay employed	Cytopathogenic effect
ptr.8084_071	ptr.8084_071	Cell line used	Madin-Darby canine kidney cell line
ptr.8084_071	ptr.8084_071	Virus	Influenza virus A
ptr.8084_071	ptr.8084_071	IC50/ED50/EC50/CC50	IC50 (6.5 μg/ml)
ptr.8084_072	ptr.8084_072	Extraction method and solvent	Methanol extract
ptr.8084_072	ptr.8084_072	Isolated compound (Class of compound)	none
ptr.8084_072	ptr.8084_072	Assay employed	Pock lesions formation
ptr.8084_072	ptr.8084_072	Cell line used	allantoic sac of chick embryos
ptr.8084_072	ptr.8084_072	Virus	Fowlpox Viruses
ptr.8084_072	ptr.8084_072	IC50/ED50/EC50/CC50	EC50 (100 ng/ml)
ptr.8084_072	ptr.8084_072	Mechanism of action	Inhibition of pock lesions formation
ptr.8084_073	ptr.8084_073	Extraction method and solvent	none
ptr.8084_073	ptr.8084_073	Isolated compound (Class of compound)	Mangiferin
ptr.8084_073	ptr.8084_073	Assay employed	Plaque reduction assay
ptr.8084_073	ptr.8084_073	Cell line used	HeLa cell lines; Vero cell lines
ptr.8084_073	ptr.8084_073	Virus	HSV-2; Acyclovir resistant HSV-1
ptr.8084_073	ptr.8084_073	IC50/ED50/EC50/CC50	EC50 (111.7 μg/ml); IC50 (2.9 μg/ml)
ptr.8084_074	ptr.8084_074	Extraction method and solvent	Hydroalcoholic extract
ptr.8084_074	ptr.8084_074	Isolated compound (Class of compound)	none
ptr.8084_074	ptr.8084_074	Assay employed	none
ptr.8084_074	ptr.8084_074	Cell line used	Baby Hamster Kidney (BHK)
ptr.8084_074	ptr.8084_074	Virus	HSV-1
ptr.8084_074	ptr.8084_074	IC50/ED50/EC50/CC50	IC50 (3.1 mg/ml)
ptr.8084_075	ptr.8084_075	Extraction method and solvent	Methanol extract
ptr.8084_075	ptr.8084_075	Isolated compound (Class of compound)	none
ptr.8084_075	ptr.8084_075	Assay employed	Cytopathic effects
ptr.8084_075	ptr.8084_075	Cell line used	Vero cells
ptr.8084_075	ptr.8084_075	Virus	HSV
ptr.8084_075	ptr.8084_075	IC50/ED50/EC50/CC50	Minimum inhibitory concentration 62.5  μg/ml
ptr.8084_076	ptr.8084_076	Extraction method and solvent	Ethanolic extract
ptr.8084_076	ptr.8084_076	Isolated compound (Class of compound)	none
ptr.8084_076	ptr.8084_076	Assay employed	Reverse Passive Haemagglutination (R-PHA) method
ptr.8084_076	ptr.8084_076	Cell line used	Chicken erythrocytes
ptr.8084_076	ptr.8084_076	Virus	HBV
ptr.8084_076	ptr.8084_076	IC50/ED50/EC50/CC50	40 mg/ml
ptr.8084_076	ptr.8084_076	Mechanism of action	anti-HBsAg
ptr.8084_077	ptr.8084_077	Extraction method and solvent	Ethanolic extract
ptr.8084_077	ptr.8084_077	Isolated compound (Class of compound)	none
ptr.8084_077	ptr.8084_077	Assay employed	Reverse Passive Haemagglutination (R-PHA) method
ptr.8084_077	ptr.8084_077	Cell line used	Chicken erythrocytes
ptr.8084_077	ptr.8084_077	Virus	HBV
ptr.8084_077	ptr.8084_077	IC50/ED50/EC50/CC50	40 mg/ml
ptr.8084_077	ptr.8084_077	Mechanism of action	anti-HBsAg
ptr.8084_078	ptr.8084_078	Extraction method and solvent	Ethanolic extract
ptr.8084_078	ptr.8084_078	Isolated compound (Class of compound)	Punicalagin
ptr.8084_078	ptr.8084_078	Assay employed	Inhibition of replication
ptr.8084_078	ptr.8084_078	Cell line used	HEp-2 cells
ptr.8084_078	ptr.8084_078	Virus	HSV-2
ptr.8084_078	ptr.8084_078	IC50/ED50/EC50/CC50	100% inhibition at 31.25 μg/ml
ptr.8084_079	ptr.8084_079	Extraction method and solvent	Hydroalcoholic extract
ptr.8084_079	ptr.8084_079	Isolated compound (Class of compound)	none
ptr.8084_079	ptr.8084_079	Assay employed	MTT
ptr.8084_079	ptr.8084_079	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_079	ptr.8084_079	Virus	HIV-1
ptr.8084_079	ptr.8084_079	IC50/ED50/EC50/CC50	EC50 (62.8 μg/ml)
ptr.8084_080	ptr.8084_080	Extraction method and solvent	Ethanolic extract
ptr.8084_080	ptr.8084_080	Isolated compound (Class of compound)	none
ptr.8084_080	ptr.8084_080	Assay employed	HIV-1protease fluorogenic assay
ptr.8084_080	ptr.8084_080	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_080	ptr.8084_080	Virus	HIV-1 protease
ptr.8084_080	ptr.8084_080	IC50/ED50/EC50/CC50	EC50 (62 μg/ml)
ptr.8084_080	ptr.8084_080	Mechanism of action	Protease inhibition
ptr.8084_081	ptr.8084_081	Extraction method and solvent	Hydroalcoholic extract
ptr.8084_081	ptr.8084_081	Isolated compound (Class of compound)	none
ptr.8084_081	ptr.8084_081	Assay employed	Cytopathogenic effect
ptr.8084_081	ptr.8084_081	Cell line used	Human cervix carcinoma (HeLa) cell lines
ptr.8084_081	ptr.8084_081	Virus	Coxsackie virus B3
ptr.8084_081	ptr.8084_081	IC50/ED50/EC50/CC50	EC50 (82.1μg/ml)
ptr.8084_082	ptr.8084_082	Extraction method and solvent	Ethanolic extract
ptr.8084_082	ptr.8084_082	Isolated compound (Class of compound)	none
ptr.8084_082	ptr.8084_082	Assay employed	Plaque reduction assay
ptr.8084_082	ptr.8084_082	Cell line used	Vero cells
ptr.8084_082	ptr.8084_082	Virus	HSV 1; Vesicular stomatitis virus; Suid herpes viruses type 1
ptr.8084_082	ptr.8084_082	IC50/ED50/EC50/CC50	MIC (0.01 mg/ml); MIC (250 µg/ml)
ptr.8084_083	ptr.8084_083	Extraction method and solvent	Methanol; Aqueous extract
ptr.8084_083	ptr.8084_083	Isolated compound (Class of compound)	Furomollugin  (naphthohydroquinone); Mollugin  (naphthohydroquinone)
ptr.8084_083	ptr.8084_083	Assay employed	MTT; Cytopathogenic effect
ptr.8084_083	ptr.8084_083	Cell line used	Human hepatoma Hep3B cells; Rhesus monkey kidney cell line (MA-104)
ptr.8084_083	ptr.8084_083	Virus	Hepatitis B ; Rotavirus multiplication
ptr.8084_083	ptr.8084_083	IC50/ED50/EC50/CC50	IC50 (2.0 µg/ml); 62.5 mg/ml
ptr.8084_083	ptr.8084_083	Mechanism of action	Suppressed the secretion of hepatitis B surface antigen (HBsAg); The extract  accelerate the induction of rotavirus-induced apoptosis in MA-104 cells, with concomitant reduction of progeny virus production
ptr.8084_084	ptr.8084_084	Extraction method and solvent	Methanol extract; Aqueous extract
ptr.8084_084	ptr.8084_084	Isolated compound (Class of compound)	none
ptr.8084_084	ptr.8084_084	Assay employed	RdRp inhibition assay
ptr.8084_084	ptr.8084_084	Cell line used	none
ptr.8084_084	ptr.8084_084	Virus	HCV
ptr.8084_084	ptr.8084_084	IC50/ED50/EC50/CC50	IC50 (15 µg/ml); IC50 (18.3 µg/ml)
ptr.8084_084	ptr.8084_084	Mechanism of action	Inhibited RNA-dependent RNA polymerase (RdRp) by 77.9% at the concentration of 50 µg/mL
ptr.8084_085	ptr.8084_085	Extraction method and solvent	Ethanol extract
ptr.8084_085	ptr.8084_085	Isolated compound (Class of compound)	none
ptr.8084_085	ptr.8084_085	Assay employed	HIV reverse transcriptase (RT) assay
ptr.8084_085	ptr.8084_085	Cell line used	MT2 cells
ptr.8084_085	ptr.8084_085	Virus	HIV 1
ptr.8084_085	ptr.8084_085	IC50/ED50/EC50/CC50	IC50 (135 µg/ml)
ptr.8084_086	ptr.8084_086	Extraction method and solvent	80% methanol
ptr.8084_086	ptr.8084_086	Isolated compound (Class of compound)	none
ptr.8084_086	ptr.8084_086	Assay employed	MTT
ptr.8084_086	ptr.8084_086	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_086	ptr.8084_086	Virus	HIV1; HIV 2
ptr.8084_086	ptr.8084_086	IC50/ED50/EC50/CC50	EC50 (>53.8 µg/ml)
ptr.8084_087	ptr.8084_087	Extraction method and solvent	Dichloromethanol extract
ptr.8084_087	ptr.8084_087	Isolated compound (Class of compound)	none
ptr.8084_087	ptr.8084_087	Assay employed	MTT
ptr.8084_087	ptr.8084_087	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_087	ptr.8084_087	Virus	HIV1; HIV 2
ptr.8084_087	ptr.8084_087	IC50/ED50/EC50/CC50	EC50 (>23.4 µg/ml)
ptr.8084_088	ptr.8084_088	Extraction method and solvent	Methanolic extract
ptr.8084_088	ptr.8084_088	Isolated compound (Class of compound)	none
ptr.8084_088	ptr.8084_088	Assay employed	Quantitative RT-PCR assay
ptr.8084_088	ptr.8084_088	Cell line used	Human Hepatoma Cell line
ptr.8084_088	ptr.8084_088	Virus	HCV
ptr.8084_088	ptr.8084_088	IC50/ED50/EC50/CC50	MNTC (100 µM)
ptr.8084_088	ptr.8084_088	Mechanism of action	Showed 37% inhibition
ptr.8084_089	ptr.8084_089	Extraction method and solvent	Ultrafiltration technology
ptr.8084_089	ptr.8084_089	Isolated compound (Class of compound)	none
ptr.8084_089	ptr.8084_089	Assay employed	Enzyme-linked immunosorbent assay (ELISA)
ptr.8084_089	ptr.8084_089	Cell line used	Human liver cell line HepG2.2.15
ptr.8084_089	ptr.8084_089	Virus	Hepatitis B Virus
ptr.8084_089	ptr.8084_089	IC50/ED50/EC50/CC50	30 μg/mL
ptr.8084_089	ptr.8084_089	Mechanism of action	Suppressed the secretion of hepatitis B surface antigen with inhibition rates of 27.92%
ptr.8084_090	ptr.8084_090	Extraction method and solvent	none
ptr.8084_090	ptr.8084_090	Isolated compound (Class of compound)	none
ptr.8084_090	ptr.8084_090	Assay employed	cytopathic effect
ptr.8084_090	ptr.8084_090	Cell line used	none
ptr.8084_090	ptr.8084_090	Virus	H1N1
ptr.8084_090	ptr.8084_090	IC50/ED50/EC50/CC50	EC50 (4.7 mg/L)
ptr.8084_091	ptr.8084_091	Extraction method and solvent	Petroleum ether extract
ptr.8084_091	ptr.8084_091	Isolated compound (Class of compound)	none
ptr.8084_091	ptr.8084_091	Assay employed	MTT
ptr.8084_091	ptr.8084_091	Cell line used	Human T-lymphocytic MT-4 cells
ptr.8084_091	ptr.8084_091	Virus	HIV1; HIV 2
ptr.8084_091	ptr.8084_091	IC50/ED50/EC50/CC50	EC50 (>78µg/ml)
ptr.8084_092	ptr.8084_092	Extraction method and solvent	Methanolic extract
ptr.8084_092	ptr.8084_092	Isolated compound (Class of compound)	none
ptr.8084_092	ptr.8084_092	Assay employed	Inhibition of replication
ptr.8084_092	ptr.8084_092	Cell line used	CD4+ T-cell line
ptr.8084_092	ptr.8084_092	Virus	HIV 1
ptr.8084_092	ptr.8084_092	IC50/ED50/EC50/CC50	IC50 (25 µg/ml)
ptr.8084_093	ptr.8084_093	Extraction method and solvent	Hydroalcoholic extract
ptr.8084_093	ptr.8084_093	Isolated compound (Class of compound)	none
ptr.8084_093	ptr.8084_093	Assay employed	none
ptr.8084_093	ptr.8084_093	Cell line used	none
ptr.8084_093	ptr.8084_093	Virus	HIV1; HIV 2
ptr.8084_093	ptr.8084_093	IC50/ED50/EC50/CC50	EC50 (>22.7µg/ml
ptr.8084_094	ptr.8084_094	Extraction method and solvent	Hydroalcoholic extract
ptr.8084_094	ptr.8084_094	Isolated compound (Class of compound)	none
ptr.8084_094	ptr.8084_094	Assay employed	none
ptr.8084_094	ptr.8084_094	Cell line used	none
ptr.8084_094	ptr.8084_094	Virus	HIV1; HIV 2
ptr.8084_094	ptr.8084_094	IC50/ED50/EC50/CC50	EC50 (>8.3 µg/ml)
ptr.8084_095	ptr.8084_095	Extraction method and solvent	Ethanol extract
ptr.8084_096	ptr.8084_096	Isolated compound (Class of compound)	none
ptr.8084_095	ptr.8084_095	Assay employed	Plaque reduction assays
ptr.8084_095	ptr.8084_095	Cell line used	Vero cells
ptr.8084_095	ptr.8084_095	Virus	Measles virus
ptr.8084_095	ptr.8084_095	IC50/ED50/EC50/CC50	Titer reduction factor of 100
ptr.8084_096	ptr.8084_096	Extraction method and solvent	Fresh ginger; Methanol extract
ptr.8084_096	ptr.8084_096	Isolated compound (Class of compound)	β-Sesquiphellandrene  (sesquiterpene)
ptr.8084_096	ptr.8084_096	Assay employed	Plaque reduction assay
ptr.8084_096	ptr.8084_096	Cell line used	Human upper respiratory tract cell lines; M-HeLa cells
ptr.8084_096	ptr.8084_096	Virus	Human respiratory syncytial virus; Rhinovirus IB
ptr.8084_096	ptr.8084_096	IC50/ED50/EC50/CC50	300 μg/ml ; IC50 (0.44 µM)
ptr.8084_096	ptr.8084_096	Mechanism of action	Decreased the plaque counts to 27.0%; Decreased the plaque counts by 50%
